Apr 15, 2020 / NTS GMT
Deborah Honig - Adelaide Capital - Analyst
Good evening. Thank you for joining us for our second BYOB. This week, we have a number of small-cap health care companies that are Canadian listed, that have applications that they're working on, that have some sort of the impact for the -- hopeful impact for that fight against COVID-19.
So I will start with some introductions. And I guess we'll start with iFabric. We have Hylton Karon and Hilton Price here, just talk a little bit about their company. So, feel free to take it away, gentlemen.
Hylton Karon - iFabric Corp - Director, President & CEO
Good afternoon, and thank you for inviting me to this BYOB, and thank you, everybody for taking the time to hear our little story. iFabric Corp is a technology company that started in the textile technology world around 2008. And we have spent the predominance of our time developing technologies against the antibacterial world in the [HAI] genre. We did a bit of testing against viruses around 2012, which is the Noro and the H1N1 viruses. And of course, with C19
iFabric Corp, Lexagene Holdings Inc and Microbix Biosystems Inc BYOB Series Hosted by Adelaide Capital Transcript
Apr 15, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers